Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Conference Proceedings
  • Disease Areas
  • Other Medical News
  • Media
    • Podcast
    • Video
    • Education
  • About
    • Conference Proceedings
    • Vacancies

Tag: COPD

Practice-changing results for ensifentrine in COPD

Presented By
Prof. Antonio Anzueto, University of Texas Health San Antonio, TX, USA
Trial
Phase 3, ENHANCE-1, ENHANCE-2
Conference
ATS 2023

12 June, 2023 16:10

Alvelestat for AATD meets primary endpoints in phase 2 trial

Presented By
Prof. Robert Stockley, University Hospital Birmingham, UK
Trial
Phase 2, ASTRAEUS
Conference
ATS 2023

12 June, 2023 16:08

Fewer exacerbations with dupilumab in COPD with type 2 inflammation

Presented By
Prof. Klaus Rabe, LungenClinic Grosshansdorf GmbH, Germany
Trial
Phase 3, BOREAS
Conference
ATS 2023

12 June, 2023 16:05

Efficient detection of AECOPD with at-home vital signs monitoring

Presented By
Mr Yann Le Guillou, Biosency, France
Conference
ATS 2023

12 June, 2023 15:55

Icenticaftor achieves results on top of triple inhalation therapy in COPD 

Presented By
Prof. Frits Franssen, Maastricht University, the Netherlands
Conference
ERS 2022

30 October, 2022 20:50

STARR2: A new approach for treating COPD exacerbations 

Presented By
Prof. Mona Bafadhel, King’s College London, UK
Trial
Phase 4, STARR2
Conference
ERS 2022

30 October, 2022 20:48

COPD medication not effective in symptomatic smokers with preserved spirometry 

Presented By
Prof. MeiLan Han, University of Michigan, MI, USA
Trial
Phase 3, RETHINC
Conference
ERS 2022

30 October, 2022 20:46

Do digital tools improve physical activity in COPD?

Presented By
Prof. Andre Nyberg, University of Umeå, Sweden
Conference
ERS 2022

30 October, 2022 20:43

Hyperpolarised gas MRI ready for clinical use

Presented By
Dr Sarah Svenningsen, McMaster University, Canada
Conference
ERS 2022

30 October, 2022 20:41

ERS 2022 Highlights Podcast

Presented By
Robert van den Heuvel, Medicom
Conference
ERS 2022

22 September, 2022 02:57

Tailored exercise needed for COPD patients

Presented By
Prof. Andre Nyberg, Umea University, Sweden
Conference
NLC 2022

17 August, 2022 16:28

Effects of passive vaping in COPD patients

Presented By
Prof. Torben Sigsgaard, Aarhus University, Denmark
Conference
NLC 2022

17 August, 2022 14:32

Three’s a crowd for triple therapy in COPD

Presented By
Prof. Claus Vogelmeier, Philipps-University Marburg, Germany
Conference
ATS 2022

18 July, 2022 12:40

Higher 1-year COPD mortality after hospitalisation for White patients

Presented By
Dr Snigdha Jain, Yale School of Medicine, CT, USA
Conference
ATS 2022

18 July, 2022 12:39

CT-evident mucus plugs in COPD associated with death

Presented By
Dr Alejandro Diaz, Brigham and Women’s Hospital, MA, USA
Trial
COPDGene
Conference
ATS 2022

18 July, 2022 12:35

Home-based rehabilitation improves COPD: a randomised study

Presented By
Dr Roberto Benzo, Mayo Clinic Rochester, MN, USA
Conference
ATS 2022

18 July, 2022 12:33

No screening evidence for COPD

Presented By
Prof. Carol Mangione, University of California at Los Angeles, CA, USA
Conference
ATS 2022

18 July, 2022 11:44

JAK inhibitors and bDMARDs not associated with increased risk of serious infections in RA

Presented By
Dr Anja Strangfeld, German Rheumatism Research Centre Berlin, Germany
Conference
EULAR 2021

2 August, 2021 23:53

Possible aetiologies for COPD exacerbations – more evidence is needed

Presented By
Prof. Surya P. Bhatt, Birmingham School of Medicine, AL, USA
Conference
ATS 2021

5 July, 2021 13:50

Does COPD plus COVID-19 equal higher mortality?

Presented By
Dr Jacob Schwartz, Lenox Hill Hospital, NY, USA
Conference
ATS 2021

5 July, 2021 13:50

Biomarkers for acute exacerbations in COPD are required

Presented By
Prof. Don D. Sin, University of British Columbia, BC, Canada
Conference
ATS 2021

5 July, 2021 13:50

Severe exacerbations: A key driver of all-cause mortality in COPD patients

Presented By
Prof. Manoj J. Mammen, Jacobs School of Medicine and Biomedical Sciences, NY, USA
Trial
Phase 3, IMPACT
Conference
ATS 2021

5 July, 2021 13:50

Men and women with COPD differ in many ways

Presented By
Dr Franziska Trudzinski, University Hospital Centre Heidelberg, Germany
Trial
Cohort study, cosyconet
Conference
ATS 2021

5 July, 2021 13:50

Younger adults with COPD at higher health risk than previously thought

Presented By
Dr Alina J. Blazer, University of Toronto, ON, Canada
Conference
ATS 2021

5 July, 2021 13:50

Inflammatory disease as a risk factor for fractures

Presented By
Dr Giovanni Adami, University of Verona, Italy
Conference
ACR 2020

18 January, 2021 10:45

The role of chronic symptoms as early biomarkers of COPD development

Presented By
Dr James Allinson, Imperial College London, UK
Conference
ERS 2020

29 October, 2020 18:29

Urgent call for studies in COPD patients aged 40-60 years

Presented By
Prof. Wisia Wedzicha , Imperial College London, UK
Conference
ERS 2020

29 October, 2020 18:25

Nasal high-flow therapy: a novel treatment option for hypercapnic COPD patients

Presented By
Dr Jens Bräunlich, Kliniken Aurich-Emden-Norden, Germany
Conference
ERS 2020

29 October, 2020 18:10

Exacerbation history is a reliable predictor of future exacerbations

Presented By
Prof. Claus Vogelmeier, Philipps University of Marburg, Germany
Trial
Cohort study, AvoidEx
Conference
ERS 2020

29 October, 2020 18:07

Singing training effective as physical rehabilitation in COPD

Presented By
Prof. Uffe Bødtger, Nætved Hospital, Denmark
Conference
ERS 2020

29 October, 2020 18:02

Current prediction tools underestimate exacerbation risk of severe COPD patients

Presented By
Mr Spencer Keene, Maastricht University, the Netherlands
Trial
ECLIPSE
Conference
ERS 2020

29 October, 2020 16:57

COPD patients derive clinical benefit from β-blockers

Presented By
Dr Anne Nielsen, Zealand University Hospital, Denmark
Conference
ERS 2019

28 November, 2019 23:58

Smart shirt as a device to measure tidal volumes in real-life setting

Presented By
Ms Denise Mannée, Radboud University Medical Centre, the Netherlands
Conference
ERS 2019

28 November, 2019 22:19

COPD patients harbouring Pseudomonas Aeruginosa face high risk of hospitalisation

Presented By
Dr Josefin Eklöf, Copenhagen University Hospital, Denmark
Conference
ERS 2019

28 November, 2019 22:01

Exercise with virtual reality beneficial for COPD patients

Presented By
Dr Sebastian Rutkowski, Opole University of Technology, Poland
Conference
ERS 2019

28 November, 2019 21:21

One blood eosinophil count is sufficient to guide ICS therapy

Presented By
Prof. Mona Bafadhel, , University of Oxford, United Kingdom
Trial
IMPACT
Conference
ERS 2019

28 November, 2019 21:03

Female COPD patients frequently suffer from anxiety and depression

Presented By
Mr El-Hassane Ouaalaya, Bordeaux University, France
Conference
ERS 2019

28 November, 2019 20:05

COPD patients do not benefit from azithromycin therapy longer than a year

Presented By
Dr Sander Talman, Amphia Hospital, the Netherlands
Trial
Cohort study, COLUMBUS
Conference
ERS 2019

28 November, 2019 16:28

Pneumococcal vaccines: an effective way to reduce COPD hospitalisations

Presented By
Prof. Antoni Torres, University Hospital Clinic Barcelona, Catalonia, Spain
Trial
CAPiTA
Conference
ERS 2019

28 November, 2019 16:06

Dual bronchodilation improves ventilation dynamics in COPD patients

Presented By
Prof. Jens Hohlfeld, Hannover Medical School, Germany
Trial
Cohort study, CLAIM
Conference
ERS 2019

28 November, 2019 15:07

CORTICO-COP trial: eosinophil-guided therapy reduces systemic corticosteroid exposure

Presented By
Dr Pradeesh Sivapalan, University of Copenhagen, Denmark
Trial
CORTICO-COP
Conference
ATS 2019

23 July, 2019 23:23

Benralizumab does not ameliorate COPD exacerbations (GALATHEA/TERRANOVA trials)

Presented By
Prof. Gerard Criner, Temple University, USA
Trial
Phase 3, GALATHEA, TERRANOVA
Conference
ATS 2019

23 July, 2019 21:35

Ensifentrine for COPD maintenance treatment

Presented By
Dr Dave Singh, University of Manchester, UK
Conference
ATS 2019

23 July, 2019 20:17

Aclidinium bromide delays COPD exacerbation without increased MACE risk

Presented By
Prof. Kenneth Chapman, University of Toronto, Canada
Trial
ASCENT-COPD
Conference
ATS 2019

23 July, 2019 11:20
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy